Heart failure woman: Does she make any difference?

Italian Heart Journal

Volumn 4, Issue 1, 2003, Pages 4-16

  Opasich, Cristina ^a   De Giuli, Federica ^a   Majani, Giuseppina ^a   Pierobon, Antonia ^a   De Feo, Stefania ^a  

^a IRCCS   (Italy)

Author keywords

Heart failure; Sex

Indexed keywords

AMIODARONE; AMLODIPINE; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; BUCINDOLOL; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN; CAPTOPRIL; CARVEDILOL; DIGITALIS; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOFETILIDE; ENALAPRIL; HYDRALAZINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IBOPAMINE; LISINOPRIL; LOSARTAN; METOPROLOL; MILRINONE; NITRIC ACID DERIVATIVE; PLACEBO; PRAZOSIN; PROSTACYCLIN; SPIRONOLACTONE; UNINDEXED DRUG; VALSARTAN;

ADULT; AGED; BLEEDING TENDENCY; BRADYCARDIA; BRAIN HEMORRHAGE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; COUGHING; DIABETES MELLITUS; DISEASE SEVERITY; DRUG CONTRAINDICATION; DRUG EFFECT; DRUG EFFICACY; FEMALE; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; HEALTH CARE QUALITY; HEART FAILURE; HUMAN; HYPERTENSION; HYPOKALEMIA; HYPOTENSION; INCIDENCE; KIDNEY DYSFUNCTION; MALE; PATHOPHYSIOLOGY; PEPTIC ULCER; PREVALENCE; QUALITY OF LIFE; RASH; REVIEW; RISK FACTOR; SEX DIFFERENCE; TASTE DISORDER; THROMBOSIS; AGE DISTRIBUTION; CONFIDENCE INTERVAL; CONGESTIVE HEART FAILURE; HOSPITALIZATION; ITALY; MIDDLE AGED; ONSET AGE; PROBABILITY; RISK; SURVIVAL RATE;

AGE DISTRIBUTION; AGE OF ONSET; AGED; CONFIDENCE INTERVALS; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; ITALY; MALE; MIDDLE AGED; ODDS RATIO; PREVALENCE; PROBABILITY; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SURVIVAL RATE;

EID: 0038287885     PISSN: 1129471X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (107)

1. Wenger KW. Women, heart failure and heart failure therapies. Circulation 2002; 105: 1526-8.
2. Phillips SJ, Whisnant JP, O'Fallon WM, Frye RL. Prevalence of cardiovascular disease and diabetes mellitus in residents of Rochester, Minnesota. Mayo Clin Proc 1990; 65: 344-59.
3. Mair FS, Crowley TS, Bundred PE. Prevalence, aetiology and management of heart failure in general practice. Br J Gen Pract 1996; 46: 77-9.
4. Rodeheffer RJ, Jacobsen SJ, Gersh BJ, et al. The incidence and prevalence of congestive heart failure in Rochester, Minnesota. Mayo Clin Proc 1993; 68: 1143-50.
5. Mittelmark MB, Psaty BM, Rautaharju PM, et al. Prevalence of cardiovascular diseases among older adults. The Cardiovascular Health Study. Am J Epidemiol 1993; 137: 311-7.
6. Landahl S, Svanborg A, Astrand K. Heart volume and the prevalence of certain common cardiovascular disorders at 70 and 75 years of age. Eur Heart J 1984; 5: 326-31.
7. Van de Lisdonk EH, Van den Bosch WJHM, Huygen FJA, Lagro-Jansen ALM. Diseases in general practice. Utrecht: Bunge, 1990.
8. Mosterd A, Hoes AW, de Bruyne MC, et al. Prevalence of heart failure and left ventricular dysfunction in the general population. Eur Heart J 1999; 20: 447-55.
9. Kitzman DW, Gardin MJ, Gottdiener JS, et al, for the CHS Research Group. Importance of heart failure with preserved systolic function in patients ≥ 65 years of age. Cardiovascular Health Study. Am J Cardiol 2001; 87: 419-23.
10. Haan MN, Selby JV, Rice DP, et al. Trends in cardiovascular disease incidence and survival in the elderly. Ann Epidemiol 1996; 6: 348-56.
11. Royal College of General Practitioners, Office of Population Census and Survey, and Department of Health and Social Security. Morbidity statistics from general practice: fourth national study, 1991-92. London: HMSO, 1995.
12. Senni M, Tribouilloy M, Rodeheffer RJ, et al. Congestive heart failure in the community. Trends in Incidence and Survival in a 10-year period. Arch Intern Med 1999; 159: 29-34.
13. Pitt B. The epidemiology of heart failure: the Framingham study. J Am Coll Cardiol 1993; 22: 6A-13A.
14. Senni M, Tribouilloy CM, Rodeheffer RJ, et al. Congestive heart failure in the community. A study of all incident cases in Olmsted country, Minnesota, in 1991. Circulation 1998; 98: 2282-9.
15. Kannel WB. Epidemiology and prevention of cardiac failure: Framingham study insights. Eur Heart J 1987; 8 (Suppl F): 23-9.
16. Sugrue DD, Rodeheffer RJ, Codd MB, Ballard DJ, Fuster V, Gersh BJ. The clinical course of idiopathic dilated cardiomyopathy. A population-based study. Ann Intern Med 1992; 117: 117-23.
17. Hillis G, Trent R, Winton P, MacLeod A, Jennings K. Angiotensin-converting enzyme inhibitors: are we ignoring the evidence? QJM 1996; 89: 145-50.
18. Andersoon B, Waagstein F. Spectrum and outcome of congestive heart failure in a hospitalized population. Am Heart J 1993; 126: 632-40.
19. Zannad F, Briancon S, Juilliere Y, et al, for the EPICAL Investigators. Incidence, clinical and etiologic features, and outcomes of advanced chronic heart failure: the EPICAL Study. Epidemiologie de l'Insuffisance Cardiaque Avancée en Lorraine. J Am Coll Cardiol 1999; 33: 734-42.
20. Cleland GF, Gemmell I, Khand A, Boddy A. Is the prognosis of heart failure improving? Eur J Heart Fail 1999; 1: 229-41.
21. McCullough PA, Philbin EF, Spertus JA, Kaatz S, Sandberg KR, Weawer WD. Confirmation of heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study. J Am Coll Cardiol 2002; 39: 60-9.
22. Fabbri G, Ambrosio G, Cafiero M, et al, on behalf of TEMISTOCLE Investigators. In-hospital outcomes of patients with heart failure by ward of admission: the TEMISTOCLE registry. (abstr) Eur J Heart Fail Suppl 2002; 1: 56.
23. Cowburn PJ, Cleland JGF, Coats AJS, Komajda M. Risk stratification in chronic heart failure. Eur Heart J 1998; 19: 696-710.
24. Tofler GH, Stone PH, Mueller JE, et al. Effects of gender and race on prognosis after myocardial infarction: adverse prognosis for women, particularly black women. J Am Coll Cardiol 1987; 9: 473-82.
25. Kimmestiel C, Goldberg RJ. Congestive heart failure in women: focus on heart failure due to coronary artery disease and diabetes. Cardiology 1990; 77 (Suppl 2): 71-9.
26. Kannel WB. Epidemiology aspects of heart failure. Cardiol Clin 1989; 7: 1-9.
27. Hoffman RM, Psaty BM, Kronmal RA. Modifiable risk factors for incident heart failure in the coronary artery surgery study. Arch Intern Med 1994; 154: 417-23.
28. Mejhert M, Holmgren J, Wändell P, Persson H, Edner M. Diagnostic tests, treatment and follow-up in heart failure patients - is there a gender bias in the coherence to guidelines? Eur J Heart Fail 1999; 1: 407-10.
29. Kannel WB, Ho K, Thom T. Changing epidemiological features of cardiac failure. Br Heart J 1994; 72: 3-9.
30. Richardson LG, Rocks MK. Women and heart failure. Heart Lung 2001; 30: 87-97.
31. Lindenfeld J, Krause-Steinrauf H, Salerno J. Where are all the women with heart failure? J Am Coll Cardiol 1997; 30: 1417-9.
32. Olivetti G, Giordano G, Corradi D, et al. Gender differences and aging: effects on the human heart. J Am Coll Cardiol 1995; 26: 1068-79.
33. Senni M, Redfield M. Defining differences in community and trial CHF patients. Cardiol Rev 1999; 16: 14-7.
34. Aronow W, Ahn C, Kronzon I. Prognosis of congestive heart failure in elderly patients with normal versus abnormal left ventricular systolic function associated with coronary disease. Am J Cardiol 1990; 66: 1257-9.
35. McLaughlin M. Rethinking estrogen function. Pittsburg: The University of Pittsburg School of Medicine, 1998.
36. Bella JN, Palmieri V, Kitzman DW, et al. Gender difference in diastolic function in hypertension (the HyperGEN study). Am J Cardiol 2002; 89: 1052-6.
37. Gardner JD, Brower GL, Janicki J. Gender differences in cardiac remodelling secondary to chronic volume overload. J Card Fail 2002; 8: 101-7.
38. Vaccarino V, Chen YT, Wang Y, Radford MJ, Krumholz HM. Sex differences in the clinical care and outcome of congestive heart failure in the elderly. Am Heart J 1999; 138: 835-42.
39. Taffet GE, Teasdale TA, Bleyer AJ, Kutka NJ, Luchi RJ. Survival of elderly men with congestive heart failure. Age Ageing 1992; 21: 49-55.
40. Wang R, Mouliswar M, Denman S, Kleban M. Mortality of the institutionalized old-old hospitalized with congestive heart failure. Arch Intern Med 1998; 158: 2464-8.
41. Rich MW, Shah AS, Vinson JM, Freedland KE, Kuru T, Sperry JC. Iatrogenic congestive heart failure in older adults: clinical course and prognosis. J Am Geriatr Soc 1996; 44: 638-43.
42. Brophy JM, Deslauriers G, Rouleau JL. Long-term prognosis of patients presenting to the emergency room with decompensated congestive heart failure. Can J Cardiol 1994; 10: 543-7.
43. Ho KKL, Anderson KM, Kannel B, Grossman W, Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 1993; 88: 107-15.
44. Schocken DD, Arrieta MI, Leaverton PE, Ross EA. Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol 1992; 20: 301-6.
45. Mosterd A, Cost B, Hoes AW, et al. The prognosis of heart failure in the general population. The Rotterdam Study. Eur Heart J 2001; 22: 1318-27.
46. Adams KF, Dunlap SH, Sueta CA, et al. Relation between gender, etiology and survival in patients with symptomatic heart failure. J Am Coll Cardiol 1996; 28: 1781-8.
47. Adams KF, Sueta CA, Gheorghiade M, et al, for the FIRST Investigators. Gender differences in survival in advanced heart failure. Insights from the FIRST Study. Circulation 1999; 99: 1816-21.
48. Croft JB, Giles WH, Pollard RA, Keenan NL, Casper ML, Anda RF. Heart failure survival among older adults in the United States. A poor prognosis for an emerging epidemic in the Medicare population. Arch Intern Med 1999; 159: 505-10.
49. Messner T, Peterson B. Clinical epidemiology of heart failure: experience in a rural hospital. J Card Fail 1996; 2: 25-9.
50. Cowie MR, Wood DA, Coats AJS, et al. The survival of patients with a new diagnosis of heart failure: a population-based study. Heart 2000; 83: 505-10.
51. Dauterman KW, Go AS, Rowell R, Gebretsadik T, Gettner S, Massie BM. Congestive heart failure with preserved systolic function in a statewide sample of community hospitals. J Card Fail 2001; 7: 221-8.
52. Opasich C, Tavazzi L, Lucci D, et al, on behalf of the Italian Network on Congestive Heart Failure (IN-CHF) Investigators. Comparison of one-year outcome in women versus men with chronic congestive heart failure. Am J Cardiol 2000; 86: 353-7.
53. MacIntyre K, Capewell S, Stewart S, et al. Evidence of improving prognosis in heart failure. Trends in case fatality in 66 547 patients hospitalized between 1986 and 1995. Circulation 2000; 102: 1126-31.
54. Philbin EF, DiSalvo TG. Influence of race and gender on care process, resources use, and hospital-based outcomes in congestive heart failure. Am J Cardiol 1998; 82: 76-81.
55. Ghali JK, Weiner DH, Greenberg B, Adams K, Benedict C, Quinones M, for the SOLVD Registry Investigators. Does gender have an impact on survival of patients with heart failure? Findings from the SOLVD Registry. (abstr) J Am Coll Cardiol 1997; 246A.
56. Aronow WS, Ahn C, Kronzon I. Prognosis of congestive heart failure after prior myocardial infarction in older men and women with abnormal versus normal left ventricular ejection fraction. Am J Cardiol 2000; 85: 1382-4.
57. Haldeman GA, Croft JB, Giles WH, Rashidee A. Hospitalization of patients with heart failure: National Hospital Discharge Survey, 1985 to 1995. Am Heart J 1999; 137: 352-60.
58. Gordon HS, Rosenthal GE. The relationship of gender and in-hospital death. Increased risk of death in men. Med Care 1999; 37: 318-24.
59. Ho KKL, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: the Framingham study. J Am Coll Cardiol 1993; 22: 6A-13A.
60. Bourassa MG, Gurne O; Bangdiwala SI, et al. Natural history and current practices in heart failure. J Am Coll Cardiol 1993; 22: 14A-19A.
61. Petrie MC, Dawson NF, Murdoch DR, Davie AP, McMurray JJV. Failure of women's hearts. Circulation 1999; 99: 2334-41.
62. Feldman DE, Thivierge C, Guérard L, et al. Changing trends in mortality and admission to hospitals for elderly patients with congestive heart failure in Montreal. CMAJ 2001; 165: 1033-6.
63. Clarke KW, Gray D, Hampton JR. Evidence of inadequate investigation and treatment of patients with heart failure. Br Heart J 1994; 71: 584-7.
64. Edep MA, Shah NB, Tateo IM, Massie BM. Differences between primary care physicians and cardiologists in management of congestive heart failure: relation to practice guidelines. J Am Coll Cardiol 1997; 30: 518-26.
65. Auerbach AD, Hamel MB, Davis RB, et al, for the SUPPORT Investigators. Resource use and survival of patients hospitalised with congestive heart failure: differences in care by specialty of the attending physician. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Ann Intern Med 2000; 132: 191-200.
66. Cohen-Solal A, Desnos M, Delahaye F, Emeriau JP, Hanania G, for the Myocardiopathy and Heart Failure Working Group of the French Society of Cardiology, the National College of General Hospital Cardiologists and the French Geriatric Society. A national survey of heart failure in French hospitals. Eur Heart J 2000; 21: 763-9.
67. Brown AM, Cleland JGF. Influence of concomitant disease on patterns of hospitalisation in patients with heart failure discharged from Scottish hospitals in 1995. Eur Heart J 1998; 19: 1063-9.
68. McMurray JJ, McDonagh TA, Morrison CE, Dargie HJ. Trends in hospitalisation from heart failure in Scotland. Eur Heart J 1993; 14: 1158-62.
69. Reitsma JB, Mosterd A, de Graen AJM, et al. Increase in hospital admission rates for heart failure in the Netherlands, 1980-1993. Heart 1996; 76: 388-92.
70. Senni M, Rodeheffer RJ, Tribouilloy CM, et al. Use of echocardiography in the management of congestive heart failure in the community. J Am Coll Cardiol 1999; 33: 164-70.
71. Hood S, Taylor S, Roeves A, et al. Are there age and gender differences in the investigation and treatment of heart failure? A population-based study. Br J Gen Pract 2000; 50: 559-63.
72. Christian MS. Introduction/overview: gender-based differences in pharmacologic and toxicologic responses. Int J Toxicol 2001; 20: 145-8.
73. Wingate S. Women and coronary heart disease: implications for the critical care setting. Focus Crit Care 1991; 18: 212-20.
74. Romeo K. The female heart: physiological aspects of cardiovascular disease in women. Dimens Crit Care Nurs 1995; 14: 170-5.
75. National Institutes of Health. Women's task force statement. Bethesda, MD: The NIH Institutes, 1990.
76. Wenger N, Speroff L, Packard B. Cardiovascular health and disease in women. N Engl J Med 1992; 329: 247-56.
77. Limacher MC, Yusuf S, for the SOLVD Investigators. Gender differences in presentation, morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD): a preliminary report. In: Wenger NK, Speroff L, Packard B, eds. Cardiovascular health and disease in women. Greenwich, CT: Le Jacq Communications, 1993: 345-8.
78. Pfeffer MA, Braunwald E, Moye LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survival and Ventricular Enlargement Trial. N Engl J Med 1992; 327: 669-77.
79. Swedberg K, Held P, Kjekshus J, et al, on behalf of the CONSENSUS II Study Group. Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction: results of the Cooperative North Scandinavian. Enalapril Survival Study II (CONSENSUS II). N Engl J Med 1992; 327: 678-84.
80. Pfeffer MA, Braunwald E, Moye LA. ACE inhibitors after myocardial infarction. (letter) N Engl J Med 1993; 328: 968.
81. Gang R, Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality in patients with heart failure. JAMA 1995; 273: 1450-7.
82. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991; 325: 293-302.
83. The SOLVD Investigators. Effect of enalapril on mortality and development of heart failure in asymptomatic patients with reduced left ventricular ejections. N Engl J Med 1992; 327: 685-91.
84. Shah M, Granger C, Bart B, et al. Sex related differences in the use and adverse effects of angiotensin-converting enzyme inhibitors in heart failure: the study of patients intolerant of converting enzyme inhibitors registry. Am J Med 2000; 109: 489-92.
85. Kostis JB, Shelton BJ, Yusuf S, et al. Tolerability of enalapril initiation by patients with left ventricular dysfunction: results of the medication challenge phase of the Studies of Left Ventricular Dysfunction. Am Heart J 1994; 128: 358-64.
86. Kostis JB, Shelton B, Gosselin G, et al. Adverse effects of enalapril in the Studies of Left Ventricular Dysfunction (SOLVD). Am Heart J 1996; 131: 350-5.
87. Simon T, Mary-Krause M, Funck-Brentano C, Jaillon P, on behalf of the CIBIS II Investigators. Sex differences in the prognosis of congestive heart failure. Results from the Cardiac Insufficiency Bisoprolol Study (CIBIS II). Circulation 2002; 103: 375-80.
88. Packer M, Coats AJ, Fowler MB, et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001; 344: 1651-8.
89. Ghali JK, Pina IL, Gottlieb SS, Deedwania PC, Wikstrand JC, on behalf of the MERIT-HF Study Group. Metoprolol CR/XL in female patients with heart failure. Analysis of the experience in Metoprolol Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF). Circulation 2002; 105: 1585-91.
90. Zannad F, Alla F, Dousset B, Perz A, Pitt B. Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure. Insights from the Randomized Aldactone Evaluation Study (RALES). Circulation 2000; 102: 2700-6.
91. Schwartz JB. Congestive heart failure medications: is there a rationale for sex-specific therapy? J Gend Specif Med 2000; 3: 17-22.
92. Clinical Quality Improvement Network Investigators. Mortality risk and patterns of practice in 4606 acute care patients with congestive heart failure: the relative importance of age, sex and medical therapy. Arch Intern Med 1996; 156: 1669-75.
93. Chin MH, Goldman L. Factors contributing to the hospitalization of patients with congestive heart failure. Am J Public Health 1997; 87: 643-8.
94. Dries DL, Rosenberg YD, Waclawiw MA, Domanski MJ. Ejection fraction and risk of thromboembolic events in patients with systolic dysfunction and sinus rhythm: evidence for gender differences in the studies of left ventricular dysfunction trials. J Am Coll Cardiol 1997; 29: 1074-80.
95. Chin MH, Goldman L. Gender differences in 1-year survival and quality of life among patients admitted with congestive heart failure. Med Care 1998; 36: 1033-46.
96. Riedinger MS, Dracup KA, Brecht M, Padilla G, Sarna L, Ganz PA. Quality of life in patients with heart failure: do gender differences exist? Heart Lung 2001; 30: 105-16.
97. Murberg TA, Bru E, Aarsland T, Svebak S. Functional status and depression among men and women with congestive heart failure. Int J Psychiatry Med 1998; 28: 273-91.
98. Weissman MM, Leaf PJ, Holzer CG III, Meyers JK, Tischler GL. The epidemiology of depression: an update on sex differences in rates. J Affect Disord 1984; 7: 179-88.
99. Nolen-Hoeksema S. Sex differences in unipolar depression: evidence and theory. Psychol Bull 1987; 101: 259-82.
100. Bertolotti G, Sanavio E, Vidotto G, Zotti AM. Un modello di valutazione psicologica in medicina riabilitativa. Pavia: Fondazione Clinica del Lavoro Edizioni, 1994.
101. DSM IV. Manuale diagnostico e statistico dei disturbi mentali. Milano: Masson, 1996.
102. Hankin BL, Abramson LY. Development of gender differences in depression: an elaborated cognitive vulnerability transactional stress theory. Psychol Bull 2001; 127: 773-96.
103. Krohne HW. Individual differences in coping. In: Zeidner M, Endler NS, eds. Handbook of coping. New York, NY. John Wiley & Sons, 1996: 381-409.
104. Krumholz HM, Butler J, Miller J, et al. Prognostic importance of emotional support for elderly patients hospitalized with heart failure. Circulation 1998; 97: 958-64.
105. Coyne JC, Rohrbaugh MJ, Shoham V, Sonnega JS, Nicklas JM, Cranford JA. Prognostic importance of marital quality for survival of congestive heart failure. Am J Cardiol 2001; 88: 526-9.
106. Martensson J, Karlsson JE, Fridlund B. Female patients with congestive heart failure: how they conceive their life situation. J Adv Nurs 1998; 28: 1216-24.
107. Evangelista LS, Kagawa-Singer M, Dracup K. Gender differences in health perceptions and meaning in persons living with heart failure. Heart Lung 2001; 30: 167-76.